These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37156497)

  • 1. Targeting the nucleotide metabolism of Trypanosoma brucei and other trypanosomatids.
    Hofer A
    FEMS Microbiol Rev; 2023 May; 47(3):. PubMed ID: 37156497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Activity Relationship Exploration of 3'-Deoxy-7-deazapurine Nucleoside Analogues as Anti-
    Hulpia F; Campagnaro GD; Alzahrani KJ; Alfayez IA; Ungogo MA; Mabille D; Maes L; de Koning HP; Caljon G; Van Calenbergh S
    ACS Infect Dis; 2020 Aug; 6(8):2045-2056. PubMed ID: 32568511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids.
    Geiger A; Bossard G; Sereno D; Pissarra J; Lemesre JL; Vincendeau P; Holzmuller P
    Front Immunol; 2016; 7():212. PubMed ID: 27303406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GMP synthase is essential for viability and infectivity of Trypanosoma brucei despite a redundant purine salvage pathway.
    Li Q; Leija C; Rijo-Ferreira F; Chen J; Cestari I; Stuart K; Tu BP; Phillips MA
    Mol Microbiol; 2015 Sep; 97(5):1006-20. PubMed ID: 26043892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of ligands targeting metacaspase-2 (MCA2) from Trypanosoma brucei brucei and their application to MCA5 from T. congolense as possible trypanocides.
    Eyssen LE; Coetzer TH
    J Mol Graph Model; 2020 Jun; 97():107579. PubMed ID: 32197135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enzymes of purine salvage in Trypanosoma cruzi, Trypanosoma brucei and Leishmania mexicana.
    Davies MJ; Ross AM; Gutteridge WE
    Parasitology; 1983 Oct; 87 (Pt 2)():211-7. PubMed ID: 6316234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis.
    Berg M; Kohl L; Van der Veken P; Joossens J; Al-Salabi MI; Castagna V; Giannese F; Cos P; Versées W; Steyaert J; Grellier P; Haemers A; Degano M; Maes L; de Koning HP; Augustyns K
    Antimicrob Agents Chemother; 2010 May; 54(5):1900-8. PubMed ID: 20194690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of different trypanosome species in the mid-guts of tsetse flies of the Malanga (Kimpese) sleeping sickness focus of the Democratic Republic of Congo.
    Simo G; Silatsa B; Flobert N; Lutumba P; Mansinsa P; Madinga J; Manzambi E; De Deken R; Asonganyi T
    Parasit Vectors; 2012 Sep; 5():201. PubMed ID: 22992486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel nucleobase/pentamidine transporters from Trypanosoma brucei.
    Ortiz D; Sanchez MA; Quecke P; Landfear SM
    Mol Biochem Parasitol; 2009 Feb; 163(2):67-76. PubMed ID: 18992774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48.
    Martínez-García M; Bart JM; Campos-Salinas J; Valdivia E; Martínez-Bueno M; González-Rey E; Navarro M; Maqueda M; Cebrián R; Pérez-Victoria JM
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):203-212. PubMed ID: 29649664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness.
    Hulpia F; Mabille D; Campagnaro GD; Schumann G; Maes L; Roditi I; Hofer A; de Koning HP; Caljon G; Van Calenbergh S
    Nat Commun; 2019 Dec; 10(1):5564. PubMed ID: 31804484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Cycle Inhibition To Treat Sleeping Sickness.
    Epting CL; Emmer BT; Du NY; Taylor JM; Makanji MY; Olson CL; Engman DM
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the intracellular survival gene kit of trypanosomatid parasites.
    Bartholomeu DC; de Paiva RM; Mendes TA; DaRocha WD; Teixeira SM
    PLoS Pathog; 2014 Dec; 10(12):e1004399. PubMed ID: 25474314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genome of the African trypanosome Trypanosoma brucei.
    Berriman M; Ghedin E; Hertz-Fowler C; Blandin G; Renauld H; Bartholomeu DC; Lennard NJ; Caler E; Hamlin NE; Haas B; Böhme U; Hannick L; Aslett MA; Shallom J; Marcello L; Hou L; Wickstead B; Alsmark UC; Arrowsmith C; Atkin RJ; Barron AJ; Bringaud F; Brooks K; Carrington M; Cherevach I; Chillingworth TJ; Churcher C; Clark LN; Corton CH; Cronin A; Davies RM; Doggett J; Djikeng A; Feldblyum T; Field MC; Fraser A; Goodhead I; Hance Z; Harper D; Harris BR; Hauser H; Hostetler J; Ivens A; Jagels K; Johnson D; Johnson J; Jones K; Kerhornou AX; Koo H; Larke N; Landfear S; Larkin C; Leech V; Line A; Lord A; Macleod A; Mooney PJ; Moule S; Martin DM; Morgan GW; Mungall K; Norbertczak H; Ormond D; Pai G; Peacock CS; Peterson J; Quail MA; Rabbinowitsch E; Rajandream MA; Reitter C; Salzberg SL; Sanders M; Schobel S; Sharp S; Simmonds M; Simpson AJ; Tallon L; Turner CM; Tait A; Tivey AR; Van Aken S; Walker D; Wanless D; Wang S; White B; White O; Whitehead S; Woodward J; Wortman J; Adams MD; Embley TM; Gull K; Ullu E; Barry JD; Fairlamb AH; Opperdoes F; Barrell BG; Donelson JE; Hall N; Fraser CM; Melville SE; El-Sayed NM
    Science; 2005 Jul; 309(5733):416-22. PubMed ID: 16020726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasite Polyamines as Pharmaceutical Targets.
    Roberts S; Ullman B
    Curr Pharm Des; 2017; 23(23):3325-3341. PubMed ID: 28571553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.